The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Activation of nuclear factor κB in inflammatory bowel disease
Open accessAbstract
Background —Expression of pro-inflammatory cytokines is increased in the intestinal lamina propria of patients with inflammatory bowel disease (IBD). Nuclear factor κB (NFκB) controls transcription of inflammation genes. On activation, NFκB is rapidly released from its cytoplasmic inhibitor (IκB), transmigrates into the nucleus, and binds to DNA response elements in gene promoter regions. Aims —To investigate whether increased activation of NFκB is important in IBD and may be down-regulated by anti-inflammatory treatment. Methods —Activation of NFκB was determined by western blot assessment and electrophoretic mobility shift assay in nuclear extracts of colonic biopsy samples as well as lamina propria mononuclear cells. Results —Nuclear levels of NFκB p65 are increased in lamina propria biopsy specimens from patients with Crohn’s disease in comparison with patients with ulcerative colitis and controls. Increased activation of NFκB was detected in lamina propria mononuclear cells from patients with active IBD. Corticosteroids strongly inhibit intestinal NFκB activation in IBD in vivo and in vitro by stabilising the cytosolic inhibitor IκBα against activation induced degradation. Conclusions —In both IBDs, but particularly Crohn’s disease, increased activation of NFκB may be involved in the regulation of the inflammatory response. Inhibition of NFκB activation may represent a mechanism by which steroids exert an anti-inflammatory effect in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other
Mann, H. B., & Whitney, D. R. (1947) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177730491 · Cited by 14,320
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
On the Kolmogorov-Smirnov Test for Normality with Mean and Variance Unknown
Lilliefors, H. W. (1967) · Journal of the American Statistical Association · doi:10.2307/2283970 · Cited by 4,530
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Osborn, L., Kunkel, S., & Nabel, G. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2336 · Cited by 1,621
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,585
Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., & Siebenlist, U. (1995) · Science · doi:10.1126/science.7878466 · Cited by 1,434
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
Rachmilewitz, D. (1989) · BMJ · doi:10.1136/bmj.298.6666.82 · Cited by 1,039
REINECKER, H.-C., STEFFEN, M., WITTHOEFT, T., PFLUEGER, I., SCHREIBER, S., MacDERMOTT, R. P., & RAEDLER, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05997.x · Cited by 856
Self-citationAn Interleukin-4-Induced Transcription Factor: IL-4 Stat
Hou, J., Schindler, U., Henzel, W. J., Ho, T. C., Brasseur, M., & McKnight, S. L. (1994) · Science · doi:10.1126/science.8085155 · Cited by 854
Neurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W. (1996) · Nature Medicine · doi:10.1038/nm0996-998 · Cited by 840
Shakhov, A. N., Collart, M. A., Vassalli, P., Nedospasov, S. A., & Jongeneel, C. V. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.1.35 · Cited by 819
Traenckner, E. B., Wilk, S., & Baeuerle, P. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06878.x · Cited by 710
Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.
Scherer, D. C., Brockman, J. A., Chen, Z., Maniatis, T., & Ballard, D. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11259 · Cited by 554
Ledebur, H. C., & Parks, T. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.933 · Cited by 545
NF-κB Subunit-Specific Regulation of the Interleukin-8 Promoter
Kunsch, C., & Rosen, C. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6137-6146.1993 · Cited by 493
MACDONALD, T. T., HUTCHINGS, P., CHOY, M.-Y., MURCH, S., & COOKE, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb03334.x · Cited by 478
Mahida, Y. R., Wu, K., & Jewell, D. P. (1989) · Gut · doi:10.1136/gut.30.6.835 · Cited by 427
Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.
Ligumsky, M., Simon, P. L., Karmeli, F., & Rachmilewitz, D. (1990) · Gut · doi:10.1136/gut.31.6.686 · Cited by 400
NF-kappa B subunit-specific regulation of the interleukin-8 promoter.
Kunsch, C., & Rosen, C. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6137 · Cited by 372
Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel disease
Stevens, C., Walz, G., Singaram, C., Lipman, M. L., Zanker, B., Muggia, A., Antonioli, D., Peppercorn, M. A., & Strom, T. B. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01300378 · Cited by 331
Isaacs, K. L., Sartor, R. B., & Haskill, S. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91182-4 · Cited by 314
Ziegler-Heitbrock, H. W., Wedel, A., Schraut, W., Ströbel, M., Wendelgass, P., Sternsdorf, T., Bäuerle, P. A., Haas, J. G., & Riethmüller, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32510-3 · Cited by 303
Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes.
Ziegler-Heitbrock, H. W. L., Sternsdorf, T., Liese, J., Belohradsky, B., Weber, C., Wedel, A., Schreck, R., Bäuerle, P., & Ströbel, M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.12.6986 · Cited by 302
Measurement of protein‐DNA interaction parameters by electrophoresis mobility shift assay
Fried, M. G. (1989) · ELECTROPHORESIS · doi:10.1002/elps.1150100515 · Cited by 270
Schreiber, S., MacDermott, R. P., Raedler, A., Pinnau, R., Bertovich, M. J., & Nash, G. S. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90729-5 · Cited by 204
Self-citationKim, H., Lee, H. S., Chang, K. T., Ko, T. H., Baek, K. J., & Kwon, N. S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4741 · Cited by 165
Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea.
Nicholls, S. J., Stephens, S., Braegger, C., Walker‐Smith, J. A., & MacDonald, T. T. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.8.757 · Cited by 119
Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease
Schreiber, S., Heinig, T., Panzer, U., Reinking, R. R., Bouchard, A., Stahl, P. D., & Raedler, A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90004-7 · Cited by 101
Self-citationEnhanced Gel Mobility Shift Assay for DNA-Binding Factors
Hassanain, H. H., Dai, W. H., & Gupta, S. L. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1400 · Cited by 43
Henell, F., & Glaumann, H. (1984) · PubMed · Cited by 40
Cited by
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Dietary phenolics: chemistry, bioavailability and effects on health
Crozier, A., Jaganath, I. B., & Clifford, M. N. (2009) · Natural Product Reports · doi:10.1039/b802662a · Cited by 1,988
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381
Metadata
- Authors
- Schreiber, S., Nikolaus, S., & Hampe, J.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1998-04-01
- Volume
- 42
- Issue
- 4
- Pages
- 477-484
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W1897551156
- Cited by
- 750
- References
- 37
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.